Analysts Set Mettler-Toledo International Inc. (NYSE:MTD) Price Target at $1,351.25

Shares of Mettler-Toledo International Inc. (NYSE:MTD) have been given a consensus recommendation of “Hold” by the nine analysts that are covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell rating, six have given a hold rating and two have issued a buy rating on the company. The average 1 year target price among brokerages that have covered the stock in the last year is $1,351.25.

Several analysts recently issued reports on MTD shares. Robert W. Baird reduced their price target on Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating for the company in a research note on Monday, November 11th. Wells Fargo & Company cut their price objective on Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating on the stock in a report on Monday, November 11th. Wolfe Research began coverage on Mettler-Toledo International in a report on Friday, December 13th. They set a “peer perform” rating on the stock. Stifel Nicolaus lowered their target price on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a report on Monday, November 11th. Finally, Evercore ISI upgraded Mettler-Toledo International from an “in-line” rating to an “outperform” rating and increased their price target for the stock from $1,375.00 to $1,450.00 in a report on Thursday, January 2nd.

Mettler-Toledo International Stock Performance

NYSE:MTD opened at $1,295.77 on Wednesday. The company has a market cap of $27.34 billion, a PE ratio of 34.94, a PEG ratio of 3.83 and a beta of 1.12. The stock has a 50-day simple moving average of $1,241.52 and a 200 day simple moving average of $1,343.99. Mettler-Toledo International has a 52-week low of $1,133.46 and a 52-week high of $1,546.93.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share for the quarter, beating analysts’ consensus estimates of $10.00 by $0.21. The firm had revenue of $954.54 million during the quarter, compared to the consensus estimate of $941.93 million. Mettler-Toledo International had a negative return on equity of 531.78% and a net margin of 21.15%. On average, research analysts predict that Mettler-Toledo International will post 40.42 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, insider Gerry Keller sold 140 shares of Mettler-Toledo International stock in a transaction dated Tuesday, December 3rd. The stock was sold at an average price of $1,254.09, for a total value of $175,572.60. Following the completion of the sale, the insider now owns 6 shares of the company’s stock, valued at approximately $7,524.54. This trade represents a 95.89 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Elisha W. Finney sold 76 shares of the stock in a transaction dated Monday, November 11th. The stock was sold at an average price of $1,311.75, for a total transaction of $99,693.00. Following the transaction, the director now owns 240 shares of the company’s stock, valued at $314,820. This represents a 24.05 % decrease in their position. The disclosure for this sale can be found here. 1.94% of the stock is currently owned by corporate insiders.

Institutional Trading of Mettler-Toledo International

A number of hedge funds and other institutional investors have recently made changes to their positions in MTD. Quest Partners LLC raised its position in shares of Mettler-Toledo International by 1,650.0% in the second quarter. Quest Partners LLC now owns 105 shares of the medical instruments supplier’s stock worth $147,000 after buying an additional 99 shares in the last quarter. Federated Hermes Inc. raised its holdings in shares of Mettler-Toledo International by 10.3% in the 2nd quarter. Federated Hermes Inc. now owns 7,667 shares of the medical instruments supplier’s stock valued at $10,715,000 after acquiring an additional 717 shares in the last quarter. Dai ichi Life Insurance Company Ltd boosted its position in shares of Mettler-Toledo International by 10.3% during the 2nd quarter. Dai ichi Life Insurance Company Ltd now owns 655 shares of the medical instruments supplier’s stock valued at $915,000 after acquiring an additional 61 shares during the last quarter. Parallel Advisors LLC grew its holdings in shares of Mettler-Toledo International by 12.9% during the second quarter. Parallel Advisors LLC now owns 192 shares of the medical instruments supplier’s stock worth $268,000 after purchasing an additional 22 shares in the last quarter. Finally, Massachusetts Financial Services Co. MA increased its position in shares of Mettler-Toledo International by 32.5% in the second quarter. Massachusetts Financial Services Co. MA now owns 142,944 shares of the medical instruments supplier’s stock worth $199,777,000 after purchasing an additional 35,048 shares during the last quarter. 95.07% of the stock is currently owned by institutional investors.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.